DK0668763T3 - Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme - Google Patents
Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdommeInfo
- Publication number
- DK0668763T3 DK0668763T3 DK94903295T DK94903295T DK0668763T3 DK 0668763 T3 DK0668763 T3 DK 0668763T3 DK 94903295 T DK94903295 T DK 94903295T DK 94903295 T DK94903295 T DK 94903295T DK 0668763 T3 DK0668763 T3 DK 0668763T3
- Authority
- DK
- Denmark
- Prior art keywords
- phenserin
- drugs
- manufacture
- treatment
- cognitive disorders
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000028698 Cognitive impairment Diseases 0.000 abstract 1
- PBHFNBQPZCRWQP-QUCCMNQESA-N [(3ar,8bs)-3,4,8b-trimethyl-2,3a-dihydro-1h-pyrrolo[2,3-b]indol-7-yl] n-phenylcarbamate Chemical compound CN([C@@H]1[C@@](C2=C3)(C)CCN1C)C2=CC=C3OC(=O)NC1=CC=CC=C1 PBHFNBQPZCRWQP-QUCCMNQESA-N 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 230000000718 cholinopositive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/980,399 US5409948A (en) | 1992-11-23 | 1992-11-23 | Method for treating cognitive disorders with phenserine |
| PCT/US1993/011423 WO1994012176A1 (en) | 1992-11-23 | 1993-11-23 | Use of phenserine to treat cognitive disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0668763T3 true DK0668763T3 (da) | 2002-06-03 |
Family
ID=25527533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94903295T DK0668763T3 (da) | 1992-11-23 | 1993-11-23 | Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5409948A (da) |
| EP (1) | EP0668763B1 (da) |
| JP (1) | JP3778363B2 (da) |
| AT (1) | ATE213411T1 (da) |
| AU (1) | AU693428B2 (da) |
| CA (1) | CA2149924C (da) |
| DE (1) | DE69331605T2 (da) |
| DK (1) | DK0668763T3 (da) |
| ES (1) | ES2173111T3 (da) |
| PT (1) | PT668763E (da) |
| WO (1) | WO1994012176A1 (da) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ297533B6 (cs) * | 1997-07-09 | 2007-01-03 | Axonyx | Použití inhibitorů butyrylcholinesterázy pro léčbu a diagnostiku Alzheimerovy choroby a demence |
| US20030125609A1 (en) * | 2001-08-03 | 2003-07-03 | Robert Becker | Method for reliable measurement in medical care and patient self monitoring |
| US6495700B1 (en) | 2002-01-09 | 2002-12-17 | Axonyx, Inc. | Process for producing phenserine and its analog |
| US20040024043A1 (en) * | 2002-03-22 | 2004-02-05 | Nigel Greig | Method for treating cognitive disorders |
| US7612078B2 (en) | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
| US7795307B2 (en) | 2003-10-21 | 2010-09-14 | Colucid Pharmaceuticals, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| US20050182044A1 (en) * | 2004-02-17 | 2005-08-18 | Bruinsma Gosse B. | Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate |
| WO2005089746A1 (en) * | 2004-03-19 | 2005-09-29 | Axonyx, Inc. | Dosage titration for treatment of cognitive disorders |
| JP2007529556A (ja) * | 2004-03-19 | 2007-10-25 | アクソニクス インコーポレイテッド | 認知障害の処置に有用なアセチルコリンエステラーゼ阻害剤およびｎ−メチル−ｄ−アスパラギン酸拮抗剤 |
| US7488736B2 (en) | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
| CA2508585A1 (en) * | 2004-06-01 | 2005-12-01 | Axonyx, Inc. | Transdermal delivery system for treatment of cognitive disorders |
| CA2509265A1 (en) * | 2004-06-08 | 2005-12-08 | Axonyx, Inc. | Methods of delaying alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and hmg coa reductase inhibitor |
| US7598265B2 (en) | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
| US7407966B2 (en) | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
| US7576211B2 (en) | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
| US20060194723A1 (en) * | 2005-02-28 | 2006-08-31 | Rabinoff Michael D | Novel medication treatment and delivery strategies for Alzheimer's Disease, other disorders with memory impairment, and possible treatment strategies for memory improvement |
| WO2006138385A2 (en) * | 2005-06-14 | 2006-12-28 | Cancog Technologies Inc.24 | Use of phenserine and analogs to treat behavioral problems and improve trainability |
| WO2008097546A2 (en) * | 2007-02-02 | 2008-08-14 | Colucid Pharmaceuticals, Inc. | Compounds that inhibit cholinesterase |
| RU2327480C1 (ru) | 2007-05-23 | 2008-06-27 | Виктор Иванович Рощин | Активный ингредиент лекарственного средства, лекарственное средство, фармацевтическая композиция и способ лечения больных с дементным синдромом |
| CN101795683A (zh) * | 2007-07-18 | 2010-08-04 | 科露西德医药品公司 | 用于促进警醒症的方法 |
| US8593728B2 (en) * | 2009-02-19 | 2013-11-26 | Toyota Motor Engineering & Manufacturing North America, Inc. | Multilayer photonic structures |
| US8114894B2 (en) | 2008-12-03 | 2012-02-14 | Nanotherapeutics, Inc. | Bicyclic compounds and methods of making and using same |
| CA2768356A1 (en) * | 2009-07-17 | 2011-01-20 | Allergan, Inc. | Compositions comprising a cholinesterase inhibitor for treating cognitive disorders |
| US20120225922A1 (en) | 2011-03-04 | 2012-09-06 | Qr Pharma | Effective Amounts of (3aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo [2,3-b]indol-5-yl Phenylcarbamate and Methods of Treating or Preventing Neurodegeneration |
| WO2017030968A1 (en) | 2015-08-14 | 2017-02-23 | Qr Pharma | Methods of treatment or prevention of acute brain or nerve injuries |
| US10111860B1 (en) | 2016-01-15 | 2018-10-30 | Aristea Translational Medicine Corporation | Compositions and methods for treating concussion |
| US10864192B2 (en) | 2016-01-15 | 2020-12-15 | Aristea Translational Medicine Corporation | Compositions and methods for inhibiting brain trauma-induced neurodegeneration and related conditions |
| WO2018217892A1 (en) | 2017-05-24 | 2018-11-29 | Qr Pharma, Inc. | Prevention or treatment of disease states due to metal dis-homeostasis via administration of posiphen to healthy or sick humans |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US479107A (en) * | 1892-07-19 | oesterreich | ||
| US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
| DE3843239C1 (da) * | 1988-12-22 | 1990-02-22 | Lohmann Therapie Syst Lts | |
| US4971992A (en) * | 1989-03-27 | 1990-11-20 | Hoechst-Roussel Pharmaceuticals Inc. | Carbonate derivatives of eseroline |
| US4996201A (en) * | 1989-08-02 | 1991-02-26 | Warner-Lambert Co. | 4-(N-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agents |
| US4914102A (en) * | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
| US5077289A (en) * | 1989-11-30 | 1991-12-31 | Hoechst Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine |
| US5171750A (en) * | 1991-09-26 | 1992-12-15 | The United States Of America As Represented By The Department Of Health And Human Services | Substituted phenserines as specific inhibitors of acetylcholinesterase |
-
1992
- 1992-11-23 US US07/980,399 patent/US5409948A/en not_active Expired - Lifetime
-
1993
- 1993-11-23 DK DK94903295T patent/DK0668763T3/da active
- 1993-11-23 PT PT94903295T patent/PT668763E/pt unknown
- 1993-11-23 AU AU57290/94A patent/AU693428B2/en not_active Ceased
- 1993-11-23 ES ES94903295T patent/ES2173111T3/es not_active Expired - Lifetime
- 1993-11-23 WO PCT/US1993/011423 patent/WO1994012176A1/en not_active Ceased
- 1993-11-23 DE DE69331605T patent/DE69331605T2/de not_active Expired - Fee Related
- 1993-11-23 CA CA002149924A patent/CA2149924C/en not_active Expired - Fee Related
- 1993-11-23 AT AT94903295T patent/ATE213411T1/de not_active IP Right Cessation
- 1993-11-23 EP EP94903295A patent/EP0668763B1/en not_active Expired - Lifetime
- 1993-11-23 JP JP51335894A patent/JP3778363B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0668763A1 (en) | 1995-08-30 |
| CA2149924C (en) | 2006-01-31 |
| JPH08505130A (ja) | 1996-06-04 |
| CA2149924A1 (en) | 1994-06-09 |
| DE69331605D1 (de) | 2002-03-28 |
| ES2173111T3 (es) | 2002-10-16 |
| ATE213411T1 (de) | 2002-03-15 |
| EP0668763B1 (en) | 2002-02-20 |
| PT668763E (pt) | 2002-08-30 |
| US5409948A (en) | 1995-04-25 |
| AU5729094A (en) | 1994-06-22 |
| WO1994012176A1 (en) | 1994-06-09 |
| JP3778363B2 (ja) | 2006-05-24 |
| AU693428B2 (en) | 1998-07-02 |
| DE69331605T2 (de) | 2002-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0668763T3 (da) | Anvendelse af phenserin til fremstillingen af lægemidler til behandlingen af kognitive sygdomme | |
| DK1574209T3 (da) | Fremgangsmåde til behandling af ophthalmiske sygdomme | |
| FI971116A7 (fi) | Fotodynaaminen terapia selektiivisessä solujen inaktivoinnissa veressä sekä immuunijärjestelmän häiriötautien hoito | |
| DE69825292D1 (de) | Verwendung von inosine zur herstellung eines medikamentes zur stimulierung des axonwachstums von zns-neuronen | |
| DE69213814D1 (de) | Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie | |
| EP0348353A3 (en) | The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| DK0501705T3 (da) | Anvendelse af tomoxetin til behandling af sygdomme i de nedre urinveje | |
| DE69424777D1 (de) | 3,4-diarylchromane zur behandlung von dermatitis | |
| RU94002133A (ru) | 6-хлор-5-фтор-3-(2-теноил)-2-оксиндол-1-карбоксамид как аналгезирующее и противовоспалительное средство | |
| LT97135A (en) | Use of melatonin in the manufacture of a medicament for treating patients suffering from drug addiction | |
| DE59605959D1 (de) | Verwendung von Immunglobulin-Präparationen zur Herstellung eines Medikaments zur oralen Verabreichung zur Behandlung und Prophylaxe chronischer Schmerzzustände | |
| PL338673A1 (en) | Application of fanquinone in treating alzheimer disease | |
| FI973185A0 (fi) | Melatoniinin käyttö lääkeriippuvuudesta kärsivien potilaiden hoitoon | |
| DE69100171D1 (de) | Synergistische kombination zur ophthalmischen verwendung. | |
| RU93050675A (ru) | Способ коррекции психофизиологического состояния человека | |
| NO984196D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
| DE68909750D1 (de) | Vorrichtung zur therapeutischen behandlung von lumbago sowie lumbago/ischias. | |
| DE69800906D1 (de) | Verwendung von Olanzapine zur Herstellung eines Arzneimittels zur Behandlung der zerebralen fokalen Ischämie | |
| ITMI941939A0 (it) | Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids | |
| KR920009403A (ko) | 수면장해 치료용 이미다조벤조디아제핀 | |
| EA200200559A1 (ru) | Способ лечения и профилактики нейродегенеративных состояний | |
| EE200100122A (et) | R-(+)-alfa-(2,3-dimetoksüfenüül)-1-[2-(4-fluorofenüül)etüül]-4-piperidiinmetanooli kasutamine unehäirete raviks | |
| RU95111888A (ru) | Способ лечения периферических поражений лицевого нерва | |
| UA22007A (uk) | Спосіб лікуваhhя хроhічhого hеспецифічhого простатиту |